Skip to main content

About your Search

20121129
20121207
Search Results 0 to 10 of about 11 (some duplicates have been removed)
environment, once google has seen that new rocketship, i see no reason why google should be any different. especially since google owns android. they need to figure out how to monetize it better. something the company is doing by releasing its own line of smartphones and tablets. google is sold out until after christmas. of the growth stocks, i got to admit i like google less than i did before the bad quarter if you're trying to figure out which of these stocks worries me the most, it's google, it's become a show-me situation. how about visa and master cad? both up decently since i recommended them in october. these are both plays in the worldwide switch from paper currency to plastic. visa and mastercard both reported strong quarters in october, they have healthy balance sheets. mastercard is winning new business all over the place. and visa announced a $1 billion buyback. even though visa has a new ceo, i'm a big fan of both stocks. i think they're both candidates to offer special dividends as the year unwinds. they've got the cash for certain. then there's the sherwin williams. the sto
investing. risk includes possible loss of principal. >>> an environment where everyone is still terrified about the potential impact of the fiscal cliff, i want to give you stocks that you can fall back on in a declining market. many strong companies, high yields. let me introduce you to weingarten, a company i've liked since '85. owns shopping centers all over the u.s. 301 income-producing properties and 11 more in various stages of development. they have a yield, doesn't have a lot of leverage. company recently sold off the portfolio of industrial assets to become a pure play on retail, and 70% of the rent it collects comes from tenants that are effectively internet resistant. they say it in their own papers. meaning they're immunized against online competition. things like supermarkets, restaurants, personal care supervisors. 93.6% occupancy rate up 200 basis points year-over-year. very bullish guidance. let's check in with drew alexander, the president and ceo of weingarten reality investors. how are you? >> pleasure. great to be here. >> now, we obviously are all very focused on the
. there are plenty of real worries out there. especially the fiscal cliff. in this grim environment you can find sectors that are holding up better than you might think. poncy says the pull back in retail might be just the moment that you want to pull the trigger to this key sector index. wouldn't that be something? stay with cramer and we will be right back. >> coming up. something is brewing. starbucks has been serving up solid returns. but could concerns about its moving to tea mean it is time to layoff the caffeine or is this your chance to fill up your cup before the shares really get percolating? cramer is grinding through the facts next. >>> tomorrow we are going to hear from one of my favorite companies and it is starbucks. having its biennial analyst day. right now it is more than ten points off its high for the year. i think it could mark the beginning of the stock's next big rally. you can follow along at actionalertsplus.com. a service that i do with the street. tomorrow i expect a terrific story. i'll give you a preview. lots of people ask me how i would approach this meeting. if i
. in this grim environment you can find sectors that are holding up better than you might think. the pull back in retail might be just the moment that you want to pull the trigger to this key sector index. wouldn't that be something? stay with cramer and we will be right back. >> coming up. something is brewing. but could concerns about it's moving to tea mean it is time to layoff the caffeine or is this your chance to fill up your cup before the shares get percolating? cramer is grinding through the facts next. welcome to chevy's year-end event. so, the 5.3-liter v-8 silverado can tow up to 9,600 pounds? 315 horsepower. what's that in reindeer power? [ laughing ] [ stops laughing ] [ male announcer ] chevy's giving more. this holiday season, trade up to get the 2012 chevy silverado all-star edition for 0% apr financing for 60 months plus $2,000 cash allowance or get a total value of $9,000. i've been a superintendent for 30 some years at many different park service units across the united states. the only time i've ever had a break is when i was on maternity leave. i have retired from doing t
environment and the latest quarter, incredibly strong. blucerchiati, off the 62 cents faces and better than expected revenues. how many of those have you had? and all this is happening despite the fact trimmable gets half of it's revenues from overseas. they have serious european exposure. it doesn't seem to be hurting. the forecast is for the country to grow up 15 to 17% over the next five years. i don't know many companies like that. the vast majority of that is coming from organic growth and those are terrific numbers but they are not pie in the sky numbers. this gives them a competitive edge. when you have something like that you can take market share left and right or raise prices dramatically, either way, you can krish the estimates. the number of analysts that covered him think the company's technology is necessary for their customer's survival. only a couple players you can say that about. sales force.com, apple. market for their measurement and equipment is very underpenetrated especially in europe with 22% penetration and asia with 12% penetration. sales force.com had good numbers
environment. it may look cheap relative to its peers. but got to have some sign fundamentals are improving. glenn in illinois had a question about celdex, promising a line of treatments for brain cancers and advanced breast cancers. the data seen so far is pretty promising. company has a rich pipeline to support its valuation. i say wait until december 8th when they pass data on an advanced breast cancer treatment. right now the stock is run too much for me to give it my blessing like the dex. up 128% year to date this month. but if we get any significant pull back after that december 8th breast cancer data gets digested, i think celldex could be better buying the weakness. the real value right now is in their brain cancer program. why don't we wait until the week after next? if you get a big pull back, i'm going to give you permission to pull the trigger. want to be sure about a price. dnyx. excuse me. what makes me -- i'm a little gun shy on these smaller biotechs because we know we've had a couple of blowups lately. that's why i'm not endorsing that thing head on. wednesday jeff from vi
Search Results 0 to 10 of about 11 (some duplicates have been removed)